$367.72
+0.40%
N/A+$1.48
Healthcare
Drug Manufacturers - General
NASDAQ
Active Trading
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and ...
Financial highlights
Latest / TTM · 6 periods
Snapshot
Latest / TTM: 2026-07-23
Gross Margin
—
Net Margin
—
P/E Ratio
—
Debt / Equity
—
Profitability
Profitability table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Gross MarginGross profit as a percentage of revenue. | 75.2% | 75.7% | 70.1% | 61.5% | 70.8% | — |
| Operating MarginOperating income as a percentage of revenue. | 29.4% | 36.3% | 28.0% | 21.7% | 29.1% | — |
| Net MarginNet income as a percentage of revenue. | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% | — |
| EBITDA MarginEBITDA divided by revenue. | 43.5% | 46.2% | 52.5% | 40.0% | 46.0% | — |
| Pre-tax MarginPre-tax profit as a percentage of revenue. | 25.8% | 27.9% | 27.9% | 13.8% | 24.4% | — |
Liquidity & leverage
Liquidity & leverage table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Current RatioCurrent assets divided by current liabilities. | 1.59 | 1.41 | 1.65 | 1.26 | 1.14 | — |
| Quick RatioLiquid assets divided by current liabilities. | 1.26 | 1.10 | 1.13 | 0.95 | 0.90 | — |
| Cash RatioCash and equivalents divided by current liabilities. | 0.66 | 0.49 | 0.60 | 0.52 | 0.36 | — |
| Debt / AssetsDebt as a share of total assets. | 54.5% | 59.8% | 66.5% | 65.4% | 60.3% | — |
| Debt / EquityDebt compared with shareholder equity. | 4.97 | 10.64 | 10.37 | 10.23 | 6.31 | — |
Operating efficiency
Operating efficiency table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Receivables TurnoverHow often receivables are collected in a year. | 4.45x | 4.12x | 3.55x | 4.46x | 3.84x | — |
| Inventory TurnoverHow often inventory is sold in a year. | 1.58x | 1.30x | 0.88x | 1.84x | 1.72x | — |
| Payables TurnoverHow often payables are paid in a year. | 4.72x | 4.08x | 5.29x | 6.74x | 4.53x | — |
| Asset TurnoverRevenue generated per dollar of assets. | 0.42x | 0.40x | 0.29x | 0.36x | 0.41x | — |
| Working Capital TurnoverRevenue generated per dollar of working capital. | 3.11x | 3.84x | 3.06x | 3.74x | 7.74x | — |
Valuation ratios
Valuation ratios table
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| P/E RatioPrice paid for each dollar of earnings. | 21.76x | 21.56x | 22.93x | 34.20x | 22.84x | — |
| P/B RatioPrice paid for each dollar of book value. | 19.14x | 38.60x | 24.73x | 23.99x | 20.34x | — |
| P/S RatioPrice paid for each dollar of sales. | 4.94x | 5.37x | 5.47x | 4.22x | 4.79x | — |
| P/FCF RatioPrice paid for each dollar of free cash flow. | 15.30x | 16.08x | 20.94x | 13.57x | 21.74x | — |
| Dividend YieldAnnual dividend divided by current share price. | 3.1% | 3.0% | 3.0% | 3.4% | 2.9% | — |